FSHR and hereditary clear cell renal cell carcinoma: In conclusion, our study suggests that molecular ultrasound imaging targeting FSHR or VEGFR-1 markers has real potential to follow-up patients with Renal Cell Carcinoma undergoing tyrosine kinase inhibitor treatment such as sunitinib.